Login
$NGEN
$1.89 +$0.07 (3.85%) After hours

Company Executives

Officer Source
Adam H. Rogers Also a director

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the 40-F annual report

Directors
8
serving now
Average tenure
5.1 years
from year joined
Director On board Committees Source
Adam H. Rogers
2022
4 years
None stated
J. Craig Thompson
2022
4 years
None stated
Krista L. McKerracher
2021
5 years
None stated
Harold M. Punnett
2017
9 years
Audit Committee
Randall E. Kaye
2020
6 years
None stated
Brian E. Bayley
2018
8 years
Audit Committee
Gianni (John) Ruffolo
2023
3 years
None stated
Neil A. Klompas
2024
2 years
Audit Committee

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No proxy statement on record

Related-party transactions come from the company’s proxy statement. NERVGEN PHARMA CORP. has not filed one with the SEC.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support